☆
Watchlist
Log in
Sign-up
BOD Australia Ltd (bod) Logo

BOD Australia Ltd (BOD)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials (10-yr)

BOD Chart

Snapshot

BOD's Principal Activity is the development and manufacture of CBD and hemp products for consumer markets in Australia and United Kingdom as well as the development, manufacture and distribution of therapeutics medicinal cannabis products based on Good Manufacturing Practice (GMP) certified cannabis extracts for medical markets.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -64.30%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,847 of 2,413
Sector Rank 167 of 210

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies CP1 / LSH / ZLD
EPS -$0.049
DPS $0.00
Book Value Per Share $0.08

Broker Consensus

BOD is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Date Heading Pages File Size Time

Corporate Overview

Bod Australia Limited (BOD, formerly Bod Australia Limited) is a cannabis centric healthcare company.Delivering products for both the consumer markets and medical markets.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Double Bay NSW 2028
Website www.bodaustralia.com
Registry Link Market Services
Auditor Nexia Sydney Audit Pty Limited
Date Listed 27 Oct 2016

Upcoming Calendar (Forecasted)

Date Event
14/07/2022 Report (Quarterly)
22/08/2022 Report (Prelim)
28/10/2022 Report (Annual)
24/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.
Show All

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr David Lewis Baker Non-Executive Director,Non-Executive Chairman Apr 2022

Mr David Lewis Baker

Non-Executive Director,Non-Executive Chairman

Mr Baker is a commercial advisor and company director with over 40 years of experience in law, investment banking, public company leadership and corporate governance. He has deep industry knowledge across a range of sectors and understanding of financial markets. Mr Baker is a co-founder of Baker Cook Advisory which is a boutique provider of outsourced legal, commercial and governance advice and mediation services for corporations and government agencies.
Mr Johannes (Hanno) Jacobus Cappon Non-Executive Director Jul 2021

Mr Johannes (Hanno) Jacobus Cappon

Non-Executive Director

Mr Cappon has experience in biochemistry, nutrition, health and innovation. He has a background in chemistry, life sciences, nutrition and health innovation and developing new consumer and healthcare solutions for commercialization. Mr Cappon is currently Chief Technology Officer at H&H, a position which he has held since January 2021. Mr Cappon's previous senior roles with international companies include VP R&D Nutritionals & Digestive Health at Bayer Consumer Health, Switzerland, as well as VP R&D Nutricia Medical Nutrition at multinational food company Danone Nutricia, Netherlands, amongst others.
Mr Akash Bedi Non-Executive Director Jul 2019

Mr Akash Bedi

Non-Executive Director

Mr Bedi is Group Senior Director of Strategy and Corporate Affairs at H&H Group. He is based in Hong Kong and is responsible for leading H&H Group's strategy and business development including mergers and acquisitions, and strategic investments for NewH2. He has extensive experience in investing in global start-ups and high growth companies with technologies and businesses that are of strategic importance to H&H Group. Akash has experience in multicultural and global environments. Prior to joining H&H Group, he was a Director of Global Consumer and Retail for HSBC for over a decade.

Mr Stephen Kelly Company Secretary Sep 2018
Mr George Livery Non-Executive Director Sep 2018

Mr George Livery

Non-Executive Director

Mr Livery has over 25 years of experience in senior roles domestically and internationally. Most relevant are his last seven years as director of strategy and corporate development at Swisse Wellness Group, a market leading wellness brand. In addition, George's executive experience is culminated in positions across multiple other industries including the role of chief executive officer at Village Cinemas Australia, chief operating officer of Village International, commercial director at Hoyts Limited, and director of operations and marketing (non-academic services) at the University of Sydney.

Ms Joanne (Jo) Patterson Chief Executive Officer,Executive Director Oct 2016

Ms Joanne (Jo) Patterson

Chief Executive Officer,Executive Director

Ms Patterson has over 20 years of experience in business and corporate strategy with exposure in Australia and international markets. She has developed a number of businesses from start-up as well as driving established organisations. Jo has held multiple CEO and Managing Director roles over her career.
Craig Weller Chief Operating Officer N/A
Show All

Director Interests

The current holdings of BOD directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
David Baker 04/04/2022 N/A 1,000,000 N/A N/A
Johannes (Hanno) Cappon 20/07/2021 0 N/A N/A N/A
Akash Bedi 30/06/2021 N/A N/A 1,000,000 N/A
George Livery 30/06/2021 300,000 20,000 2,800,000 N/A
Joanne (Jo) Patterson 30/06/2021 N/A 6,550,000 462,238 N/A
Show All

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Oct 15, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
New H2 Limited 14,864,865 14.03%
HSBC Custody Nominees (Australia) Limited 10,056,315 9.49%
Health And Beauty Enterprise Pty Limited 5,750,000 5.43%
Noir Ted Pty Ltd 4,852,329 4.58%
Awj Family Pty Ltd 4,445,346 4.20%
Sanlam Private Wealth Pty Ltd 2,500,000 2.36%
Gp Securities Pty Ltd 2,275,416 2.15%
Citicorp Nominees Pty Limited 2,150,592 2.03%
Calama Holdings Pty Ltd 1,332,590 1.26%
Awj Family Pty Ltd (i) 1,216,084 1.15%
Yoix Pty Ltd 1,010,000 0.95%
Baker Cook Advisory Pty Ltd 1,000,000 0.94%
Jimbzal Pty Ltd 1,000,000 0.94%
Twenty Ten Enterprises Pty Ltd 900,050 0.85%
Ms Suzanne Taylor 897,671 0.85%
National Nominees Limited 887,408 0.84%
Jgc Patterson Pty Ltd 800,000 0.76%
Symington Pty Ltd 521,360 0.49%
Mr Kenneth George Parnell & Mrs Lynette Ann Parnell 500,000 0.47%
Bond Street Custodians 441,176 0.42%
Mr John Anthony Redpath 425,901 0.40%
Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 386 1,732 531 824 88 3,561

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Joanne Patterson 15/10/2021 6,550,000 6.18
Health and Happiness (H and H) Hong Kong Limited 15/10/2021 14,864,865 14.03
SG Hiscock & Company Limited 15/10/2021 10,201,728 9.64

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
12-08-21 SG Hiscock & Company Limited 2,341,520 8.60 9.64

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
BOD Historical Price Data (CSV)
Up to 20 years of EOD share price history
Sign up to Download
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.